Axsome Therapeutics, Inc. (AXSM)
145.04
-11.03
(-7.07%)
USD |
NASDAQ |
Oct 23, 16:00
145.40
+0.36
(+0.25%)
After-Hours: 20:00
Axsome Therapeutics Price to Book Value : 91.06 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 91.06 |
| October 22, 2026 | 97.98 |
| October 21, 2026 | 98.13 |
| October 20, 2026 | 100.19 |
| October 19, 2026 | 97.82 |
| October 16, 2026 | 98.66 |
| October 15, 2026 | 101.58 |
| October 14, 2026 | 101.85 |
| October 13, 2026 | 98.14 |
| October 12, 2026 | 104.22 |
| October 09, 2026 | 105.69 |
| October 08, 2026 | 106.78 |
| October 07, 2026 | 108.59 |
| October 06, 2026 | 109.45 |
| October 05, 2026 | 111.17 |
| October 02, 2026 | 112.54 |
| October 01, 2026 | 114.31 |
| September 30, 2026 | 115.76 |
| September 29, 2026 | 116.86 |
| September 28, 2026 | 121.73 |
| September 25, 2026 | 122.48 |
| September 24, 2026 | 123.07 |
| September 23, 2026 | 121.45 |
| September 22, 2026 | 127.51 |
| September 21, 2026 | 129.01 |
| Date | Value |
|---|---|
| September 18, 2026 | 130.45 |
| September 17, 2026 | 134.53 |
| September 16, 2026 | 133.08 |
| September 15, 2026 | 128.12 |
| September 14, 2026 | 135.97 |
| September 11, 2026 | 138.59 |
| September 10, 2026 | 132.54 |
| September 09, 2026 | 132.24 |
| September 08, 2026 | 130.47 |
| September 04, 2026 | 129.76 |
| September 03, 2026 | 130.81 |
| September 02, 2026 | 131.79 |
| September 01, 2026 | 127.34 |
| August 31, 2026 | 124.64 |
| August 28, 2026 | 124.95 |
| August 27, 2026 | 129.50 |
| August 26, 2026 | 130.05 |
| August 25, 2026 | 129.00 |
| August 24, 2026 | 128.95 |
| August 21, 2026 | 130.44 |
| August 20, 2026 | 130.61 |
| August 19, 2026 | 136.99 |
| August 18, 2026 | 135.41 |
| August 17, 2026 | 135.78 |
| August 14, 2026 | 134.15 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 35.39 |
| Filana Therapeutics, Inc. | 0.4826 |
| CorMedix, Inc. | 1.323 |
| Eloxx Pharmaceuticals, Inc. | 1.113 |
| Breakthrough Chemistry, Inc. | 2.044 |
Price to Book Value Related Metrics
| PS Ratio | 9.509 |
| Price | 145.04 |
| Earnings Yield | -2.59% |
| Market Cap | 7.586B |